CAS 22131-35-7

Butalamine

Description:

Butalamine, with the CAS number 22131-35-7, is an organic compound classified as an amine. It features a butyl group attached to an amino group, which contributes to its basic properties. This compound is typically characterized by its ability to participate in various chemical reactions due to the presence of the amino functional group, making it a potential candidate for applications in pharmaceuticals and organic synthesis. Butalamine is generally a colorless to pale yellow liquid, exhibiting moderate solubility in water and good solubility in organic solvents. Its molecular structure allows it to engage in hydrogen bonding, influencing its physical properties such as boiling point and melting point. Additionally, butalamine may exhibit biological activity, which can be explored for potential therapeutic uses. However, safety and handling precautions should be observed, as with many amines, due to possible irritant effects. Overall, butalamine's unique characteristics make it a compound of interest in both industrial and research settings.

Formula: C₁₈H₂₈N₄O

InChI: InChI=1S/C18H28N4O/c1-3-5-13-22(14-6-4-2)15-12-19-18-20-17(21-23-18)16-10-8-7-9-11-16/h7-11H,3-6,12-15H2,1-2H3,(H,19,20,21)

InChI key: InChIKey=VYWQZAARVNRSTR-UHFFFAOYSA-N

SMILES: N(CCN(CCCC)CCCC)C1=NC(=NO1)C2=CC=CC=C2

Synonyms:

• 1,2,4-Oxadiazole, 5-[[2-(dibutylamino)ethyl]amino]-3-phenyl-
• 1,2-Ethanediamine N1,N1-dibutyl-N2-(3-phenyl-1,2,4-oxadiazol-5-yl)-
• 1,2-Ethanediamine, N,N-dibutyl-N'-(3-phenyl-1,2,4-oxadiazol-5-yl)-
• 1,2-Ethanediamine, N¹,N¹-dibutyl-N²-(3-phenyl-1,2,4-oxadiazol-5-yl)-
• 22131-35-7
• 3-Phenyl-5-(dibutylaminoethylamino)-1,2,4-oxadiazole
• 5-[[2-(Dibutylamino)ethyl]amino]-3-phenyl-1,2,4-oxadiazole
• N,N-dibutyl-N'-(3-phenyl-1,2,4-oxadiazol-5-yl)ethane-1,2-diamine
• N¹,N¹-Dibutyl-N²-(3-phenyl-1,2,4-oxadiazol-5-yl)-1,2-ethanediamine
• Butalamine
• Butalamine

Butalamine

CAS: 22131-35-7

Butalamine is a fatty acid ester that has been shown to exhibit a range of biological properties, including anti-inflammatory, anticancer, and anthelmintic activity. It has also been shown to be effective in the treatment of infectious diseases and autoimmune diseases. Butalamine exhibits its anti-inflammatory effects by inhibiting the production of prostaglandins (PGs) and leukotrienes (LTs). This inhibition leads to reduced inflammation, which helps with symptoms associated with microbial infection. Butalamine also has anticancer activity in animal models. The drug inhibits cancer cell proliferation by blocking the synthesis of DNA and RNA in the nucleus. Butalamine is most commonly used as an analog for butyl amine, which is used as a pharmaceutical dosage form.

Formula: C₁₈H₂₈N₄O

Purity: Min. 95%

Color and Shape: Brown Powder

Molecular weight: 316.44 g/mol

Ref: 3D-FB19369

Butalamine

CAS: 22131-35-7

Butalamine is a vasodilator (peripheral) with local anesthetic effects. It suppresses state 3 respiration and decreases ADP/O in the rat liver.

Formula: C₁₈H₂₈N₄O

Color and Shape: Solid

Molecular weight: 316.44

Ref: TM-T25184